Effects of a 3-month course of rosuvastatin in patients with systemic lupus erythematosus

Autor: Maarten Limper, H. ten Cate, Eelco W. Meesters, J de Ruiter, Hjalmar R. Hansen, E. C. M. van Gorp, M D de Kruif, Ajda T. Rowshani, C. A. Spek, I J ten Berge
Přispěvatelé: Other departments, Amsterdam institute for Infection and Immunity, Cancer Center Amsterdam, Center of Experimental and Molecular Medicine, Nephrology, Faculteit der Geneeskunde
Jazyk: angličtina
Rok vydání: 2009
Předmět:
Zdroj: Annals of the rheumatic diseases, 68(10). BMJ Publishing Group
Annals of the Rheumatic Diseases, 68(10). BMJ Publishing Group
ISSN: 0003-4967
Popis: Systemic lupus erythematosus (SLE) is associated with a highly increased cardiovascular risk. Statins can reduce this risk, but may possess additional anti-inflammatory effects that are relevant for the treatment of SLE. In a preliminary study, we investigated the effects of a 3-month course of rosuvastatin on lipids and markers of inflammation using a randomised cross-over design. The study was approved by the institutional medical and ethical committee and written informed consent was obtained from all subjects. Based upon a previous, representative study,1 a sample size of 14 patients would be necessary to demonstrate a 25% reduction in C-reactive protein (CRP) levels (power = 80%). A dropout level of 35% (n = 5) was estimated.2 Patients with stable …
Databáze: OpenAIRE